Nanalyze August 27, 2020

When you’re a young male, you spend your money on cheap booze, hard drugs, and fast women – and the rest you waste. As you enter old age, you increase your spending on drugs, the type needed to treat the chronic problems you developed from abusing your body so much during your youth. The end result is more than $1.2 trillion spent last year on drugs produced by the pharmaceutical industry.

Drugs are big business, but investing in biotech stocks is extremely risky due to the regulatory risks involved, the uncertainty around a drug’s efficacy and safety, and the cost of taking a drug candidate to market which a pharmaceutical company incurs whether the drug gets approved or not. From...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Precision Medicine, Technology
Digital Innovation Plus AI Tech Can Future-Proof the Enterprise
The AI frenzy could fall flat as companies hoard chips without enough data centers to host them
New AI drug discovery powerhouse Xaira rises with $1B in funding
EU regulation: AI Act will mean a raft of new requirements for ‘high-risk’ systems
Why nurses are protesting AI

Share This Article